TWINBEECH CAPITAL LP - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 312 filers reported holding NOVOCURE LTD in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWINBEECH CAPITAL LP ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$6,975,395
-41.1%
431,913
+51.5%
0.13%
-42.7%
Q2 2023$11,834,804
+136.5%
285,176
+242.8%
0.23%
+131.7%
Q1 2023$5,003,708
+2294.1%
83,201
+2660.5%
0.10%
+1022.2%
Q2 2022$209,000
-77.0%
3,014
-72.5%
0.01%
-77.5%
Q1 2022$907,000
-76.8%
10,951
-79.0%
0.04%
-82.1%
Q4 2021$3,915,000
+149.8%
52,147
+124.1%
0.22%
-64.3%
Q1 2020$1,567,000
+295.7%
23,266
+394.9%
0.62%
+443.5%
Q4 2019$396,0004,7010.12%
Other shareholders
NOVOCURE LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$29,071,00012.94%
HARTLINE INVESTMENT CORP/ 302,194$67,033,0008.47%
Deep Track Capital, LP 1,000,000$82,850,0005.31%
MORGAN JESS S & CO INC 48,860$4,048,0002.94%
Taylor Frigon Capital Management LLC 73,014$6,049,0002.24%
Private Harbour Investment Management & Counsel, LLC 13,263$1,099,0000.92%
HighVista Strategies LLC 17,448$1,446,0000.92%
COURAGE CAPITAL MANAGEMENT LLC 10,000$829,0000.79%
Lloyd Park, LLC 6,700$555,0000.61%
Rhenman & Partners Asset Management AB 69,700$5,775,0000.57%
View complete list of NOVOCURE LTD shareholders